To facilitate its goal of fostering department transformation, the Partnership for Undergraduate Life Sciences Education (PULSE) organizes some of its work into five geographic regions and leverages the expertise of the PULSE Fellows in each region. This article examines how these Regional Networks have driven department-level changes through outreach activities, use of the PULSE Rubrics as a diagnostic tool to help departments to advance the Vision and Change recommendations, and implementation of the PULSE framework to address local needs and challenges. We present impact data through Regional Network activities and identify commonalities in successes and challenges across all the geographic regions. Through reports from the Northeast, Southeast, Southwest, Northwest, and Midwest Great Plains, we highlight each Regional Network’s accomplishments in influencing the adoption of PULSE strategies to implement the Vision and Change recommendations to transform departments.
Following a comprehensive review, the International Society of Sports Nutrition (ISSN) has developed an official position on the role of dietary antioxidants in exercise and sport. Antioxidants play a complex, context-dependent role in vivo; they can facilitate recovery from exercise but may also hinder training adaptations when consumed at supraphysiological doses. While endogenous antioxidant systems can effectively maintain redox balance, dietary sources, particularly whole foods, can help mitigate excessive oxidative stress following intense/heavy training or inadequate recovery. The influence of dietary antioxidants depend on timing, dosage, type, and individual factors. The ISSN's official position encompasses the following: (1) Redox balance exists on a spectrum, with mild oxidative eustress driving beneficial physiological adaptations and excessive oxidative distress impairing health, recovery, and performance; (2) Moderate levels of exercise-induced reactive oxygen and nitrogen species (ROS/RNS) can support training adaptations but excessive levels can result in muscle damage, inflammation, and reduced physical performance and immune function; (3) Endogenous and exogenous antioxidants protect cells by neutralizing free radicals and reducing oxidative damage to biomolecules; (4) FDA labeling for "antioxidant" claims applies to nutrients with established RDIs and demonstrated antioxidant activity; this typically includes vitamins C and E, β-carotene (a source of vitamin A), selenium, zinc, copper, and manganese; (5) While dietary antioxidants show potential for both direct and indirect effects, the evidence varies, and their use should be tailored to individual performance or recovery goals; (6) Long-term exercise augments endogenous antioxidant defense and should be the primary strategy for enhancing redox capacity before considering supplementation; (7) Whole foods and beverages rich in flavonoids, polyphenols, carotenoids, vitamins, and minerals are preferred antioxidant sources; (8) Dietary supplementation is best reserved for nutrient insufficiencies or deficiencies, inadequate dietary intake, or periods of high training distress; (9) Responses to supplementation vary by individual factors, such as training status, baseline antioxidant capacity, demographics, diet, and injury risk, with some antioxidant compounds offering cognitive, behavioral, or physical-related benefits; and (10) Creatine monohydrate (i.e. 0.1 g/kg/day), omega-3 fatty acids (1000-6000 mg/day EPA+DHA for 6-12 weeks), tart cherry (480 mg powder or 60-90 mL juice/day for 7-14 days), and astaxanthin (4-12 mg/day for 4-12 weeks) rank among the top nutrients for their antioxidant effects, with moderate- to high-quality evidence supporting their use in recovery or performance without interfering with training adaptations. Most others show weak or low efficacy. This position promotes an individualized, evidence-based approach, recognizing that small to moderate exercise-induced oxidative stress aids adaptation, while excess oxidative stress causes harm; it also emphasizes food-forward and dietary supplementation strategies.
Background Creatine is one of the most extensively studied ergogenic aids, with over three decades of research supporting its role in exercise performance, recovery, and health.Methods This narrative review summarizes the historical development of creatine supplementation and evaluates evidence regarding its mechanisms, efficacy across active, athletic populations (e.g. strength, endurance, team-sport), and tactical (e.g. military, law enforcement) populations, and its safety profile.Results The evidence suggests that creatine enhances phosphocreatine resynthesis and cellular energy availability, resulting in consistent improvements in high-intensity exercise performance, training adaptations, lean body mass, strength, and power. Additional findings indicate that creatine may attenuate exercise-induced muscle damage and inflammation, support recovery, and improve functional outcomes following strenuous activity. Emerging research suggests benefits for endurance and team-sport athletes through enhanced glycogen resynthesis, calcium handling, oxidative stress mitigation, and repeated-sprint performance. In tactical populations, creatine may support occupational readiness by improving strength, hydration status, thermoregulation, cognition, sleep quality, and recovery, with possible neuroprotective and cardiometabolic implications. Soccer-specific evidence demonstrates improvements in repeated-sprint ability and tolerance to high training loads, with preliminary data suggesting protective effects against neurotrauma and gut barrier disruption. Importantly, pooled analyses from hundreds of clinical trials report no greater incidence of adverse events compared with placebo, reinforcing creatine's established safety profile.Conclusion Overall, the evidence suggests that creatine is a versatile supplement with strong evidence to enhance performance and recovery across diverse populations. Future research should prioritize individualized dosing strategies, long-term outcomes in underrepresented groups, and exploration of novel therapeutic applications in health and disease
This paper examines the moral formation of the protagonist of the film The Secret Life of Walter Mitty (2013) through the framework of Aristotelian virtue ethics. Though extensive research has been conducted on the use of film as a vehicle for moral education and a tool for ethics pedagogy, there exists a demonstrable gap in research which applies the principles of virtue ethics to character analysis in film. This paper presents a scene-based, qualitative analysis comparing the actions of the main character to the model of habituation of virtue as presented in The Nicomachean Ethics by Aristotle. In observing the state of the protagonist's moral posture chronologically, it will be demonstrated that his character arc engages with familiar virtue ethics concepts such as habituation (ethos), disposition (hexis), practical wisdom (phronesis), friendship (philia), contemplation (theōria), and ultimately eudaimonia. The concluding arguments will present Walter Mitty’s moral development as a roadmap to understanding his personal journey to eudaimonia through habituation, supportive friendships, and engagement with reality. Finally, a film analysis framework constructed on the tenets of virtue ethics will be proposed using this film as a case study. The analysis in this paper is intended to contribute to evolving conversations surrounding film philosophy, ethics pedagogy, and narrative screenwriting by encouraging contemporary filmmakers to adopt similar patterns of character formation which can depict authentic human flourishing on screen.
The brain accounts for approximately 2% of the total body mass yet it consumes about 20% of the daily energy expenditure. These energetic demands are further elevated during periods of metabolic stress, including sleep deprivation, hypoxia, forced mental fatigue, mood disorders, and traumatic brain injury (TBI). Creatine monohydrate supplementation (CrM) plays a critical role in brain bioenergetics via the phosphocreatine (PCr) energy system, which acts as a spatial and temporal buffer by rapidly regenerating adenosine triphosphate (ATP) from adenosine diphosphate (ADP). Accordingly, CrM has been proposed as a potential neuroprotective intervention, particularly under conditions of metabolic stress. This narrative review examines both the mechanistic rationale and empirical evidence supporting this role. CrM has been shown to increase brain creatine content by 3–10%, enhance PCr availability, stabilize intracellular pH, and support mitochondrial function. These physiological effects are associated with attenuated cognitive declines during acute sleep deprivation and hypoxia, improved executive function under forced mental fatigue, and reduced depressive symptoms, especially when used adjunctively with standard therapies. In the context of TBI, preclinical studies in rodents demonstrate reduced cortical damage and improved bioenergetics, while limited but promising pediatric clinical data suggest improved recovery outcomes with CrM supplementation. Collectively, the existing body of research indicates that CrM can enhance brain creatine content and bioenergetic capacity, which is associated with improvements in cognitive function. Despite these promising findings, the current body of evidence remains limited. Large, well-designed randomized controlled trials are needed to establish optimal dosing strategies, determine population-specific efficacy, and evaluate long-term neurological outcomes associated with CrM supplementation.